1Derisi JL, Iyer VR, Brown PO. Exploring the metabolic and genetic controls of gene expression on a genomic scale. Science, 1997,278:680 - 686.
2Caronti B, Calderaro C, Passarelli F, Palladini G, Pontieri FE.Dopmine receptor mRNAs in the rat lymphocytes. Life Sci, 1998,62(21): 1919 - 1925.
3Goumain M, Voisin T, Lorinet AM, Laburthe M. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.Biochem Biophys Res Commun, 1998, 247(1): 52-56.
4Itoh Z, Nakaya M, Suzuki T, Arai H, Wakabayashi K. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol, 1984.247(6 Pt 1): G688 - G694.
5Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, Muls E et al.Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med,1990, 322(15): 1028 - 1031.
6Peeters T, Matthijs G, Depoortere I, Cachet T, Hoogmartens J,Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol, 1989, 257(3 Pt 1): G470 -G474.
7Satoh M, Sakai T,Sano I,Fujikura K, Koyama H, Ohshhna K, Itoh Z et al. An erythromycin derivative, is a potent motilin receptor agonist in human gastric antrum. J Pharmacol Exp Ther, 1994, 271(1): 574 - 579.
8Tack J, Janssens J, Vantrappen G, Peeters T, Annese V, Depoortere I,Muls E et al. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology, 1992, 103:72 -79.
9Yamano M,. Kamato T, Nagakura Y Miyata K. Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol, 1997, 356(1): 145 - 150.
10Takahashi N, Nagai Y,Ueno S, Saeki Y,Yanagihara T. Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the two pseudogenes. FEBS Lett, 1992, 314(1 ): 23 -25.
